Erratum to ‘Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100815] - Federico Cappuzzo, MD; Zanete Zvirbule, MD; Ernesto Korbenfeld, MD; Jaroslaw Kolb-Sielecki, MD; Dolores Isla, MD, PhD; Aleksandra Szczesna, MD, PhD; Amparo Yovanna Castro Sanchez, PhD; Alberto Bustillos, MD; Xiaoyan Liu, PhD; Fiona Young, MbChB; Nadia Tosti, PhD; Marta Freitas Monteiro, MSc, PhD; et al. (JTO Clinical and Research Reports)